Right on the heels of not one, but two CAR-T approvals in the U.S., Bristol Myers Squibb is bolstering its commercial cell therapy ambitions on the other side of the Atlantic. The company on Thursday pegged Leiden, Netherlands, as the home of its first cell therapy factory in Europe and its fifth worldwide. With planning for site design and… Read More »
By Layal Liverpool We don’t know why some people who have allergies lose their sense of smellRuslan Nassyrov / Alamy Stock Photo Mice have tens of thousands of chemical sensing nose cells that can cause an allergic reaction. Researchers say this discovery could help us understand how the immune system reacts to inhaled allergens and… Read More »
FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease Print this page SOUTH SAN FRANCISCO, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta™ (voxelotor) tablets for the treatment of sickle cell disease (SCD) in adults and children… Read More »
“Oh my God, is that guy gonna jump off the bridge?” Musso remembers saying. The man had climbed on the outside of the chain-link fence barrier. He was making his way toward the center of the bridge over a busy road below, according to Musso. They immediately called 911, and then began to drive off… Read More »
Sometimes, it is hard to believe that just 25 years ago, few people had cell phones. Now, it’s hard to imagine life without them. Of course, cell phones have come a long way from their original function of simply allowing us to make calls while away from home: expanding to offer texting capabilities, mobile computing,… Read More »